257 related articles for article (PubMed ID: 35915405)
1. Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol.
Boehme C; Domig L; Komarek S; Toell T; Mayer L; Dejakum B; Krebs S; Pechlaner R; Bernegger A; Mueller C; Rumpold G; Griesmacher A; Vigl M; Schoenherr G; Schmidauer C; Ferrari J; Lang W; Knoflach M; Kiechl S
BMC Cardiovasc Disord; 2022 Aug; 22(1):347. PubMed ID: 35915405
[TBL] [Abstract][Full Text] [Related]
2. Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol.
Toell T; Boehme C; Mayer L; Krebs S; Lang C; Willeit K; Prantl B; Knoflach M; Rumpold G; Schoenherr G; Griesmacher A; Willeit P; Ferrari J; Lang W; Kiechl S; Willeit J
BMC Neurol; 2018 Nov; 18(1):187. PubMed ID: 30400876
[TBL] [Abstract][Full Text] [Related]
3. STROKE-CARD care to prevent cardiovascular events and improve quality of life after acute ischaemic stroke or TIA: A randomised clinical trial.
Willeit P; Toell T; Boehme C; Krebs S; Mayer L; Lang C; Seekircher L; Tschiderer L; Willeit K; Rumpold G; Schoenherr G; Griesmacher A; Ferrari J; Knoflach M; Lang W; Kiechl S; Willeit J;
EClinicalMedicine; 2020 Aug; 25():100476. PubMed ID: 32954239
[TBL] [Abstract][Full Text] [Related]
4. Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack.
Zhang L; Shi J; Pan Y; Li Z; Yan H; Liu C; Lv W; Meng X; Wang Y
Stroke Vasc Neurol; 2021 Sep; 6(3):376-383. PubMed ID: 33526631
[TBL] [Abstract][Full Text] [Related]
5. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2015 Oct; (10):CD010693. PubMed ID: 26511368
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2014 Jan; (1):CD010693. PubMed ID: 24399670
[TBL] [Abstract][Full Text] [Related]
8. Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack Patients.
Van Schaik SM; Van den Berg-Vos RM; Weinstein HC; Bosboom WM
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1378-82. PubMed ID: 25804570
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
[TBL] [Abstract][Full Text] [Related]
10. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
11. The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke.
Harrison SL; Lane DA; Buckley BJR; Chatterjee K; Alobaida M; Shipley E; Lip GYH
Vasc Health Risk Manag; 2022; 18():313-318. PubMed ID: 35502192
[TBL] [Abstract][Full Text] [Related]
12. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
Hobeanu C; Lavallée PC; Charles H; Labreuche J; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Molina CA; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut E; Wong KSL; Amarenco P;
Lancet Neurol; 2022 Oct; 21(10):889-898. PubMed ID: 36115361
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin: its clinical role in cerebrovascular prevention.
Gaspardone A; Arca M
Drugs; 2007; 67 Suppl 1():55-62. PubMed ID: 17910521
[TBL] [Abstract][Full Text] [Related]
14. Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial.
Leistner S; Michelson G; Laumeier I; Ahmadi M; Smyth M; Nieweler G; Doehner W; Sobesky J; Fiebach JB; Marx P; Busse O; Köhler F; Poppert H; Wimmer ML; Knoll T; Von Weitzel-Mudersbach P; Audebert HJ
BMC Neurol; 2013 Jan; 13():11. PubMed ID: 23347503
[TBL] [Abstract][Full Text] [Related]
15. Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial.
MacKay-Lyons M; Gubitz G; Giacomantonio N; Wightman H; Marsters D; Thompson K; Blanchard C; Eskes G; Thornton M
BMC Neurol; 2010 Dec; 10():122. PubMed ID: 21143864
[TBL] [Abstract][Full Text] [Related]
16. RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial.
Edwards D; Fletcher K; Deller R; McManus R; Lasserson D; Giles M; Sims D; Norrie J; McGuire G; Cohn S; Whittle F; Hobbs V; Weir C; Mant J
Trials; 2013 Jul; 14():194. PubMed ID: 23819476
[TBL] [Abstract][Full Text] [Related]
17. The Alberta Stroke Prevention in TIAs and mild strokes (ASPIRE) intervention: rationale and design for evaluating the implementation of a province-wide TIA triaging system.
Jeerakathil T; Shuaib A; Majumdar SR; Demchuk AM; Butcher KS; Watson TJ; Dean N; Gordon D; Edmond C; Coutts SB;
Int J Stroke; 2014 Oct; 9 Suppl A100():135-43. PubMed ID: 23088263
[TBL] [Abstract][Full Text] [Related]
18. Efficiency and effectiveness of intensive multidisciplinary follow-up of patients with stroke/TIA or myocardial infarction compared to usual monitoring: protocol of a pragmatic randomised clinical trial. DiVa (Dijon vascular) study.
Béjot Y; Soilly AL; Bardou M; Duloquin G; Pommier T; Laurent G; Cottin Y; Vadot L; Adam H; Boulin M; Giroud M
BMJ Open; 2023 Apr; 13(4):e070197. PubMed ID: 37185649
[TBL] [Abstract][Full Text] [Related]
19. Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.
Lavallée PC; Charles H; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Labreuche J; Molina C; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut É; Wong LKS; Amarenco P;
Lancet Neurol; 2023 Apr; 22(4):320-329. PubMed ID: 36931807
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Rehabilitation for transient ischaemic Attack and Mild Stroke: the CRAMS effectiveness-implementation hybrid study protocol.
Freene N; Wallett H; Flynn A; Preston E; Cowans S; Lueck C; Niyonsenga T; Mohanty I; Davey R
BMC Health Serv Res; 2022 Nov; 22(1):1391. PubMed ID: 36419153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
